FMP
SIGA Technologies, Inc.
SIGA
NASDAQ
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
8.23 USD
-0.28 (-3.4%)
About
ceo
Dr. Diem Nguyen M.B.A., Ph.D.
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.siga.com
exchange
NASDAQ
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
CIK
0001010086
ISIN
US8269171067
CUSIP
826917106
Address
31 East 62nd Street
Phone
212 672 9100
Country
US
Employee
45
IPO Date
Sep 10, 1997
Summary
CIK
0001010086
Exchange
NASDAQ
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
826917106
ISIN
US8269171067
Country
US
Price
8.23
Beta
0.97
Volume Avg.
774.19k
Market Cap
585.08M
Shares
-
52-Week
4.22-10.0
DCF
22.37
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
8.66
P/B
-
Website
https://www.siga.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest SIGA News
It looks like there's no news available.
